. We examined whether human NK cells die after engagement in cytolytic functions. Peripheral blood NK cells, with and without prior activation in vitro with interleukin-2 (IL-21, were tested for the occurrence of cell death after incubation with K562, the prototype NK-sensitive target cell. A proportion (15.2%) of NK cells that were stimulated for 3 days with IL-2 and then incubated for 4 hours with K562 cells showed rapid cell death, but NK cells not stimulated P ROGRAMMED CELL DEATH occurs in most tissues during animal development and throughout life and is believed to represent a general mechanism that helps to regulate the number of cells in a given organism.' In some mammalian cells, programmed cell death follows deprivation of exogenous signals that the cell requires to survive.2 In other cells, programmed cell death occurs in response to exogenous death signal^.^,^ It has been proposed that cells may elect suicide rather than repair damage, a process associated with risks of genetic error.','
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by precipitation with a saturated (NH&S04 solution and passage over protein-G Sepharose beads (Pharmacia, Piscataway, NJ). Purified antibodies to CD36 (OKM5) were obtained from Ortho Diagnostics Systems (Raritan, NJ); purified antibodies to CD22 (Leu-14) and fluorescein-labeled antibodies to CD16 (Leu 11) and CD56 (Leu 19) were obtained from Becton Dickinson (Mountain View, CA). Recombinant IL-2 was provided by Amgen (Thousand Oaks, CA).
Preparation of NK cells and IL-2-activated NK cells. NK cells were obtained essentially as described." Leukocyte-rich leukapheresis byproducts from healthy donors (National Institutes of Health Blood Bank, Bethesda, MD) were subjected to density centrifugation first over Ficoll-Hypaque (LSM; Organon Technika-Cappel, Durham, NC) to obtain mononuclear cells and then over 47% Percoll (Pharmacia) to deplete the high-density T-and B-cell fractions. Subsequently, the cells were depleted of monocytes by adherence to plastic dishes over 1 hour. The resulting mononuclear cell population was further depleted of T cells, B cells, and monocytes by addition of mouse monoclonal antibodies to CD5, CD22, and CD36 followed by incubation (2 cycles at 4°C for 30 minutes) with magnetic beads coated with a goat antimouse IgG polyclonal antiserum (Perspective Diagnostics, Cambridge, MD) and exposure to a magnetic field. The negatively selected cell population was then stained for CD16 and/ or CD56, and the percentage of positivity was determined by flow cytometry. The percentage of NK cells (CD16' and/or CD56+ cells) ranged between 85% and 95%.
Activation of NK cells was achieved by culture (2 X lo6 cells/ mL) with IL-2 (100 U/mL) for 1 to 7 days in RPM1 1640 culture medium (Biofluids, Rockville, MD) supplemented with 10% heat inactivated fetal calf serum (Reheis; Armour Pharmaceutical, Kankakee, IL), 2 mmoVL L-glutamine (GIBCO, Grand Island, W ) , and 50 pg/mL gentamicin (Sigma, St Louis, MO).
"Cr release assays. The cytolytic activity of NK cells and activated NK cells was measured in standard assays." Briefly, target K562 cells were labeled with Nazs'CrO, (New England Nuclear, Boston, MA), washed, and then incubated with effector cells at effector-to-target (E:T) ratios of 20: 1, 6 Evaluation of cell viability. Cell viability and morphology were evaluated by fluorescence microscopy after staining with acridine orange (AO) and ethidium bromide (EB), as described."." Briefly, 2 pL of a stock solution containing 100 pg/mL A 0 and 100 pg/mL EB was added to 50 pL cell suspension containing 1 X lo3 NK or activated NK cells and 3 X lo' K562 cells. After mixing, IO pL of the cell suspension was placed on a glass microscope slide, covered with a coverslip, and examined by fluorescence microscopy (Nikonoptiphot, equipped with a 510 nm dicroic mirror; Nikon, Instrument Division, Garden City, NY).
Evaluarion of apoprosis. DNA fragmentation was evaluated as described previously.** Briefly, NK Fig  1A) as well as higher (data not shown) T:E ratios resulted in a diminished percentage of specific "Cr release from the effector-activated NK cells. In contrast, NK cells that had been precultured in medium alone, without IL-2, did not undergo cell death as determined by this assay. This difference between IL-2-activated and nonactivated NK cells could not be attributed to a difference in the specific "Cr uptake because the spontaneous release of radioactivity ranged between 8.5% and 11.1% of maximum release of radioactivity in both cell populations. In conventional cytotoxicity assays run in parallel, we found that NK cells cultured in medium for 3 days and NK cells cultured with IL-2 for 3 days induced 86% versus 92% specific lysis of target K562 cells and 12% versus 96% specific lysis of the NKresistant UCLA-SO-M14 cells at an E:T ratio of 20:l.
In 14 additional experiments, the mean specific "Cr release from effector 3-day IL-2-activated NK cells incubated with target K562 cells at a T:E ratio of 3:1 was 15.2% (x/: 1.2, mean x/: SEM). In parallel experiments, the mean specific "Cr release from NK cells cultured in medium alone for 3 days and subsequently incubated with target K562 cells at a T:E ratio of 3: 1 was -2.0% (x/: 0.5). This difference is significant ( P = .OOO1 by paired two-tailed Student's t test).
These findings document that a proportion of activated but not resting NK cells reproducibly undergo cell lysis after incubation with target K562 cells.
Because these results indicated that activation was required for NK cells to die after incubation with target K562 cells, kinetics of activation were assessed. As shown ( Fig  IB) , maximum "Cr release by labeled NK cells (incubated with unlabeled target K562 cells for 4 hours at a T:E ratio of 3: 1) was observed after 3-day incubation with IL-2. NK cells activated with IL-2 for I, 5, or 7 days showed lower degrees of cell death as measured in this assay. This reduction in percentage of specific lysis after 3-day stimulation with E -2 is attributable, in part, to an increase of the difference between maximum and spontaneous release after 3 days of culture. In addition, no specific "Cr release was measured in NK cells cultured in medium alone for 1, 3, 5, and 7 days and subsequently incubated with K652 cells. These findings showed that, after 3-day activation with IL-2 in vitro, a proportion of NK cells undergo rapid cell death when incubated with target K562 cells.
Apoptosis in activated NK cells incubated with target cells. We were interested in determining whether death in activated NK cells incubated with target K562 cells occurred by apoptosis or necrosis. Fluorescence microscopy was used to morphologically characterize cells stained with A 0 and EB. Both A 0 and EB intercalate DNA and stain nuclei green and orange, respectively. A 0 stains green both viable and nonviable cells, whereas EB stains orange the nonviable cells only.2o
Purified NK cells were first cultured for 3 days either in medium alone or with L -2 to produce activated NK cells and then were mixed with K562 cells at a T:E ratio of 3:l. Subsequently, these cell mixtures were either stained immediately with A 0 and EB (Fig 2, time 0) , or incubated for 4 hours and then stained with A 0 and EB (Fig 2, 4 hours). K562 cells can be distinguished visually from NK or activated NK cells because of their larger size (Fig 2) . Some of the smaller cells, representing either NK or activated NK cells, appeared in close proximity to the larger K562 cells both at time 0 and after 4 hours of incubation. All cells, including the larger K562 cells as well as the smaller NK and activated NK cells, appeared mostly viable when examined at time 0 (ie, stained green). In contrast, after 4 hours of incubation, a number of cells appeared dead (ie, stained orange). Some K562 cells, identified by their larger size, appeared dead in coculture with either NK or activated NK cells. This presumably reflected the occurrence of K652 killing by NK or activated NK cells that was not prominent because of the low (1 :3) E:T ratio used. Importantly, some of the L-2-activated NK cells incubated for 4
hours with K562 cells showed condensed and fragmented nuclei (indicated by the arrows; see Fig 2) that stained either green or orange, which is indicative of apoptosis. Consistent with their failure to release 51Cr in coculture with K562 cells, nonstimulated NK cells did not show evidence of cell death in these cocultures (Fig 2) . These results supported the occurrence of apoptosis in activated NK cell populations incubated with target K562 cells.
To further determine that activated NK cells undergo apoptotic cell death, transmission electron microscopy was also used to show morphological changes. By this method, there was no evidence of apoptosis in NK cells activated for 3 days with L -2 and then cultured alone for 3 hours (not shown). Virtually all the cells in this culture showed the ultrastructural features of activated NK cells. These included a low nuclear-to-cytoplasmic ratio, indented nuclei, and dispersed cytoplasmic organelles, including granules that varied in number, size, and elecron-density (Ferrarini and GrossiZ3 and data not shown). In contrast, apoptotic cells were recognized in NK cell populations activated for 3 days with IL-2 and subsequently incubated with target K562 cells (T:E ratio, 3:l). This was evidenced by the occurrence of chromatin condensation, nuclear margination, and separation of nuclear components in cells with intact, smooth surface membranes (Fig 3) . The cells with ultrastructural evidence of apoptosis were not K562 cells, from which they are clearly distinguishable by their smaller size; rather, they closely resembled the cells present in cultures containing activated NK cells alone, except for the ultrastructural evidence of apoptosis. Thus, activated NK cells show characteristic features of apoptotic cells after incubation with target K562 cells.
DNA fragmentation in NK and activated NK cells. Because death by apoptosis is often associated with DNA fragmentation, we assessed whether DNA fragmentation occurs in activated NK cells exposed to target K562 cells. cells was calculated from measurements of radioactivity present on glass fiber filters that retain intact cells, as described?' As shown in Fig 4A, when activated NK cells were incubated with K562 cells at a T:E ratio of 3:l for 1 to 16 hours, a proportion of labeled DNA derived from activated NK cells was found not to be associated with intact cells. In a representative experiment (Fig 4A) , maximum DNA fragmentation, calculated at 14%, was reached after 4 hours of incubation with K562 cells. In a parallel experiment, we determined the percentage of specific lysis within the K.-2-activated NK cells (Fig 4B) . To this end, activated NK cells labeled with "Cr were incubated for 16 hours with unlabeled target K562 cells at a ratio of 1:3 (identical conditions as those used in the experiment shown in Fig 4A) , and the specific radioactivity released by NK cells was measured. As shown (Fig 4B) , maximum specific cells lysis reached 8% after 4 hours of incubation. Thus, DNA fragmentation and cell lysis temporally coincided in activated NK cells cultured with target K562 cells.
Time-course experiments (Fig 4C) indicated that 3-day culture with L -2 was optimal for NK cell maturation into cells was observed at a T E ratio of 3: 1 (Fig 4D) . Together, these experiments show that activated NK cells consistently undergo DNA fragmentation when incubated with target K562 cells.
DISCUSSION
Previous studies have shown that T-cell receptor engagement in activated T cells leads to death by apoptosis, suggesting that this might be a very important mechanism for thymic selection and extrathymic t~lerance.'"~~ A similar receptor-induced regulation was recently described for NK cell^.'^.'^ After activation with either IL-2 or IL-12, NK cells were found to die by apoptosis when CD16, a ligand for Ig Fc, was cross-linked by either anti-CD16 antibody or aggregated Ig; however, the physiological role of Fc receptor-mediated apoptosis in L-2-or IL-12-activated NK cells is presently ~n c l e a r . '~. '~ In this study, we have examined whether triggering of NK cells for cytolysis might induce cell death by apoptosis.
We have shown that, after activation with IL-2 and incubation with K562 target cells, a proportion of NK cells rapidly died. In contrast, NK cells not activated with IL-2, failed to die when incubated with K562 cells under conditions identical to those associated with activated NK cell death. This suggested that activation-derived signals are necessary for target-induced killing of NK cells. Although the nature of these activation signals is presently unknown, it is of interest that activation was also required for T and NK cells to die after T-cell-receptor triggering and CD16 cross-linking, re~pectively.''~'~ In the present system, 15.2% of the cells within activated NK cell populations were found to die within a 4-hour period of incubation with appropriate targets. This level of cell death is somewhat lower than the 22% to 30% figure reported after CD16 cro~s-linking,'~.'' but it would lead to the elimination of many of the cells within a 24-hour period.
Morphologically, target-induced death of activated NK cell populations had the features of death by apoptosis5 because it was characterized by nuclear condensation and fragmentation, as detected by light and elecron microscopy, and was associated with evidence of DNA fragmentation, as evidenced by release of radiolabeled DNA from the cells. That NK cells, rather than other contaminating cells,. were undergoing apoptosis was shown by electron microscopy. By this method, the cells with ultrastructural evidence of apoptosis also had ultrastructural characteristics of NK cells.23 These findings, combined with previous descriptions of apoptosis in NK cells treated with corticosteroids2' and in activated NK cells treated with anti-CD16 antibody, show that these cells are equipped with all the tools and molecular programs required for its occurrence.'.'
The molecular mechanisms by which apoptosis is executed in various cells and circumstances are just beginning to be unraveled',' and were not investigated here. It is interesting that c-Myc expression was required for activated NK to die after stimulation with anti-CD16, because treatment of these cells with antisense oligonucleotides to c-Myc reduced both expression of c-Myc and the occurrence of apoptosis.'' These data, combined with the observation that NK cells required IL-2 activation to be susceptible to target-induced death by apoptosis, raise the possibility that expression of c-Myc andor other activation-induced genes might also be required in the system described here. However, a variety of genes and gene products other than c -M~c '~.~" have been implicated in the control of apoptosis, including ~5 3 ,~'~~' B~1-2,3~-~' MAX,36 ~2 1 ,~" '~ and Rb: 9 suggesting that further studies will be required to address their role(s) in targetinduced apoptosis of activated NK cells.
Not addressed here were the apoptosis-initiating signals, presumably delivered to activated NK cells by the target K562 cells. It is of interest that CD16-initiated death of activated NK cells appeared to be dependent on tyrosine kinases, because it was inhibited by herbimycin A and it was speculated that it might require signaling through the 6 chain associated with CD16." Cell-cell interactions such as those involved in E:T killing are likely to deliver intracellular signals that differ in complexity from those generated from cross-linking of a surface receptor such as CD16.".*' Numerous additional surface ligands, including integrins, Fas and CD2, are believed to be involved in E T interactions, and additional work will be necessary to dissect those ligands and intracellular pathways involved in triggering a cell death signal. Because the surface molecule Fas was reported not to be expressed on NK cells,4° we were interested in excluding its involvement in target-mediated apoptosis of lymphokine-activated killer cells. However, in preliminary experiments, we found Fas to be expressed in NK cells on activation with L-2, raising the possibility that Fas might be involved (not shown).
Target-dependent apoptosis in activated NK cells may have important implications for regulation of inflammatory processes involving NK cells. Early in the course of many viral and bacterial infections, NK cells become activated to proliferate, to maximize their cytotoxic functions, and to express a variety of cytokine genes.24 As a result, NK cells may play a primary role in directing the outcome of an
For personal use only. on August 30, 2017. by guest www.bloodjournal.org From immune response to viral and bacterial pathogens." Later in the course of the infection, when antigen-specific T-cellmediated responses are established, the need for antigennonspecific functions may be decreased and further expansion of NK cells may not be desirable. The finding, reported here, that activated NK cells undergo target cell-induced apoptosis provides a mechanism for regulation of NK cell expansion during the initial steps of an immune response. Immune complexes may represent an additional mechanism of NK cell control, by promoting NK cell apoptosis during the latest stages of an immune response."
Previous studies have suggested that individual NK cells can kill multiple targets, ie, have a recycling capacity, albeit modest in magnitude, even after activation with L-2. 41, 42 Other studies have shown that NK cells can proliferate in response to target cells, particularly in concert with L-2.4' Thus, the engagement of activated NK cells with their targets can have conflicting outcomes, including cell survival associated with functional integrity:1s42 cell proliferation:* and cell death, described here. Moreover, because death occurs in only a proportion of the cells during a given time frame, detection of all these events is not mutually exclusive.
IL-2-activated NK cells, L-2-activated tumor-infiltrating lymphocytes, and L -2 have been used as investigational therapeutics for the treatment of various malignancies. In spite of transferring or inducing large numbers of NK cells with increased tumoricidal activity, these therapeutic modalities have often shown limited clinical benefit.433" It could be that activated NK cells rapidly die by apoptosis once they encounter tumor cell targets, and, thus, their presence in the patient may be transient. Potentially, drugs capable of protecting activated NK cells from apoptosis might be found that could be useful as adjuvants for NK cell-based therapies.
